FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2974515083> ?p ?o ?g. }

• W2974515083 abstract "Vol. 127, No. 9 Science SelectionOpen AccessBPA Replacement Chemical Concern: New Evidence from a Mouse Model of Endometriosisis accompanied byUse of a Mouse Model of Experimentally Induced Endometriosis to Evaluate and Compare the Effects of Bisphenol A and Bisphenol AF Exposure Silke Schmidt Silke Schmidt Search for more papers by this author Published:19 September 2019CID: 094004https://doi.org/10.1289/EHP5298View Article in:中文版AboutSectionsPDF ToolsDownload CitationsTrack CitationsCopy LTI LinkHTMLPDF ShareShare onFacebookTwitterLinked InRedditEmail Abstract“BPA-free” labels on consumer products imply that these products are safer than versions containing the plasticizer bisphenol A (BPA). But a growing body of evidence suggests that chemical replacements for BPA, such as bisphenol AF (BPAF), may pose a greater risk to human health than the original compound. A recent study published in Environmental Health Perspectives adds to this evidence.1 Using a mouse model of endometriosis, investigators at the University of Cincinnati College of Medicine found that BPAF exhibited more potent endocrine activity than BPA.Endometriosis affects an estimated 10 million American women and girls of reproductive age.2 Its most debilitating symptoms include chronic pelvic pain and fertility problems. The disease appears to arise when tissue from the uterine lining (endometrium) escapes from the uterus and attaches itself to sites in the peritoneal cavity. This is thought to occur by “retrograde menstruation,” in which menstrual tissue flows back into the cavity3; however, retrograde menstruation occurs in about 90% of women,3 whereas only 10% develop endometriosis.4 Therefore, other factors likely come into play.Endometriosis affects an estimated 10 million American women and girls of reproductive age. The incidence of endometriosis has risen since the 1970s, but the reasons why are unclear. By one estimate, endometriosis cost more than $12,000 in direct and indirect medical costs per patient in the year after diagnosis.2 Image: © iStockphoto/nensuria.Little is known about environmental factors that may contribute to endometriosis, but epidemiologic studies have reported higher levels of BPA in urine5 and serum6 samples of women with the condition. This, and the growing use of BPA analogs in manufacturing, led the Cincinnati team to perform their study.“Our earlier in vitro studies7 of several BPA substitutes found BPAF to be the most estrogenic compound,” says senior author Katherine Burns, an assistant professor in the Department of Environmental Health. “That is why we focused on BPA and BPAF, its chemically more stable analog, in our mouse models.”The researchers induced endometriosis in both hormonally intact and ovariectomized (i.e., lacking endogenous estrogen) mice by transferring minced uterine tissue from donor mice into the peritoneal cavity of host females. Prior to the transfer, the mice were fed one of three chemicals: BPA, BPAF, or ethinyl estradiol (EE), a synthetic form of estrogen. Three different doses included the no- and lowest-observed-adverse-effect levels (determined by risk assessors) plus a concentration calculated by the authors to represent documented human exposures. A fourth group of animals served as controls. Six weeks later, the investigators evaluated the number and relative size of lesions at the endometrial implant sites, while in the intact animals, they examined the ovaries.Earlier animal studies by Burns8 and others9 found that the initiation of endometriosis involves inflammatory processes, while disease progression is hormonally driven. Consistent with those findings, the current study showed that the chemicals did not affect the number of initial lesions. However, all bisphenol doses increased the number of dead oocytes in the ovaries (a phenomenon that, in women, could lead to oocyte depletion and possibly premature menopause). In this regard, the ovary was more sensitive to low-dose BPAF than low-dose BPA.In ovariectomized mice, the bisphenols stimulated lesion growth and increased the expression levels of genes targeted by the estrogen receptor. High-dose BPAF had a stronger effect on lesion weight and volume (measures of disease progression) than high-dose BPA. In intact mice, the highest dose of BPAF, but not EE or BPA, arrested the estrous cycle, which is the equivalent of the menstrual cycle in women.A strength of this design was the use of both intact and ovariectomized mice. “Most animal models of endometriosis focus on mice whose ovaries were removed,” says Romana Nowak, a professor of animal sciences at the University of Illinois at Urbana-Champaign, who was not involved in the study. “What makes this study unique is its use of intact mice who still produce their own estrogen. This is a physiologically more relevant model for human endometriosis.”The study also addresses the importance of considering life stage when studying endocrine disruptors. “Many of our [endocrine disruptor] animal models have focused on exposures during critical developmental windows, such as the prenatal period, so people may assume that adult animals are less likely to be affected because they make their own hormones,” says Laura Vandenberg, an associate professor of environmental health science at the University of Massachusetts Amherst, who was not involved in the study. “But the mice in this study were only exposed during adulthood, which shows that this assumption is [sometimes] incorrect.”For Burns, one of the most striking findings was that the highest BPAF levels eliminated the estrous cycle in intact mice. This suggests a disruption of the normal hormonal feedback loop at doses comparable to BPA levels measured in human samples. She says, “Now that we have demonstrated a stronger estrogenic effect of BPAF [compared with BPA], an important next step will be to study exactly how this [endocrine disruptor] competes with endogenous hormones in intact mice.”Silke Schmidt, PhD, writes about science, health, and the environment from Madison, Wisconsin.References1. Jones RL, Lang SA, Kendziorski JA, Greene AD, Burns KA. 2018. Use of a mouse model of experimentally induced endometriosis to evaluate and compare the effects of bisphenol A and bisphenol AF exposure. Environ Health Perspect 126(12):127004–127014, PMID: 30675821, 10.1289/EHP3802. Link, Google Scholar2. Soliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J. 2018. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther 35(3):408–423, PMID: 29450864, 10.1007/s12325-018-0667-3. Crossref, Medline, Google Scholar3. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. 1984. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64(2):151–154, PMID: 6234483. Medline, Google Scholar4. Syrop CH, Halme J. 1987. Peritoneal fluid environment and infertility. Fertil Steril 48(1):1–9, PMID: 3109960, 10.1016/S0015-0282(16)59280-2. Crossref, Medline, Google Scholar5. Upson K, Sathyanarayana S, De Roos AJ, Koch HM, Scholes D, Holt VL. 2014. A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis. Hum Reprod 29(11):2457–2464, PMID: 25205760, 10.1093/humrep/deu227. Crossref, Medline, Google Scholar6. Cobellis L, Colacurci N, Trabucco E, Carpentiero C, Grumetto L. 2009. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed Chromatogr 23(11):1186–1190, PMID: 19444800, 10.1002/bmc.1241. Crossref, Medline, Google Scholar7. Li Y, Perera L, Coons LA, Burns KA, Tyler Ramsey J, Pelch KE, et al.2018. Differential in vitro biological action, coregulator interactions, and molecular dynamic analysis of bisphenol A (BPA), BPAF, and BPS ligand-ERα complexes. Environ Health Perspect 126(1):017012, PMID: 29389661, 10.1289/EHP2505. Link, Google Scholar8. Burns KA, Thomas SY, Hamilton KJ, Young SL, Cook DN, Korach KS. 2018. Early endometriosis in females is directed by immune-mediated estrogen receptor alpha and IL-6 cross-talk. Endocrinology 159(1):103–118, PMID: 28927243, 10.1210/en.2017-00562. Crossref, Medline, Google Scholar9. Hastings JM, Fazleabas AT. 2006. A baboon model for endometriosis: implications for fertility. Reprod Biol Endocrinol 4(S1):S7, PMID: 17118171, 10.1186/1477-7827-4-S1-S7. Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsRelated articlesUse of a Mouse Model of Experimentally Induced Endometriosis to Evaluate and Compare the Effects of Bisphenol A and Bisphenol AF ExposureDec 6, 2018, 12:00:00 AMEnvironmental Health Perspectives Vol. 127, No. 9 September 2019Metrics Downloaded 285 times About Article Metrics Publication History Manuscript received8 March 2019Manuscript accepted13 March 2019Originally published19 September 2019 Financial disclosures License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days." @default.
• W2974515083 created "2019-09-26" @default.
• W2974515083 creator A5017596515 @default.
• W2974515083 date "2019-09-01" @default.
• W2974515083 modified "2023-10-05" @default.
• W2974515083 title "BPA Replacement Chemical Concern: New Evidence from a Mouse Model of Endometriosis" @default.
• W2974515083 cites W1482806521 @default.
• W2974515083 cites W1485621599 @default.
• W2974515083 cites W1596773677 @default.
• W2974515083 cites W2024144436 @default.
• W2974515083 cites W2155375240 @default.
• W2974515083 cites W2755967472 @default.
• W2974515083 cites W2788721046 @default.
• W2974515083 cites W2791561881 @default.
• W2974515083 cites W2904543591 @default.
• W2974515083 doi "https://doi.org/10.1289/ehp5298" @default.
• W2974515083 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6791412" @default.
• W2974515083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31536391" @default.
• W2974515083 hasPublicationYear "2019" @default.
• W2974515083 type Work @default.
• W2974515083 sameAs 2974515083 @default.
• W2974515083 citedByCount "2" @default.
• W2974515083 countsByYear W29745150832022 @default.
• W2974515083 countsByYear W29745150832023 @default.
• W2974515083 crossrefType "journal-article" @default.
• W2974515083 hasAuthorship W2974515083A5017596515 @default.
• W2974515083 hasBestOaLocation W29745150831 @default.
• W2974515083 hasConcept C107872376 @default.
• W2974515083 hasConcept C126322002 @default.
• W2974515083 hasConcept C185592680 @default.
• W2974515083 hasConcept C2779522080 @default.
• W2974515083 hasConcept C71924100 @default.
• W2974515083 hasConcept C99454951 @default.
• W2974515083 hasConceptScore W2974515083C107872376 @default.
• W2974515083 hasConceptScore W2974515083C126322002 @default.
• W2974515083 hasConceptScore W2974515083C185592680 @default.
• W2974515083 hasConceptScore W2974515083C2779522080 @default.
• W2974515083 hasConceptScore W2974515083C71924100 @default.
• W2974515083 hasConceptScore W2974515083C99454951 @default.
• W2974515083 hasIssue "9" @default.
• W2974515083 hasLocation W29745150831 @default.
• W2974515083 hasLocation W29745150832 @default.
• W2974515083 hasLocation W29745150833 @default.
• W2974515083 hasLocation W29745150834 @default.
• W2974515083 hasOpenAccess W2974515083 @default.
• W2974515083 hasPrimaryLocation W29745150831 @default.
• W2974515083 hasRelatedWork W1983547475 @default.
• W2974515083 hasRelatedWork W2141170103 @default.
• W2974515083 hasRelatedWork W2356476264 @default.
• W2974515083 hasRelatedWork W2360993163 @default.
• W2974515083 hasRelatedWork W2363199080 @default.
• W2974515083 hasRelatedWork W2375032663 @default.
• W2974515083 hasRelatedWork W2383760906 @default.
• W2974515083 hasRelatedWork W2748952813 @default.
• W2974515083 hasRelatedWork W2899084033 @default.
• W2974515083 hasRelatedWork W2978151344 @default.
• W2974515083 hasVolume "127" @default.
• W2974515083 isParatext "false" @default.
• W2974515083 isRetracted "false" @default.
• W2974515083 magId "2974515083" @default.
• W2974515083 workType "article" @default.